Sutro Biopharma, Inc.STRONASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank78
3Y CAGR-58.5%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
-58.5%/yr
vs -6.1%/yr prior
Acceleration
-52.4pp
Decelerating
Percentile
P78
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 7.47% |
| 2024 | -71.61% |
| 2023 | -3245.00% |
| 2022 | 104.35% |
| 2021 | -20.47% |
| 2020 | -4.27% |
| 2019 | -612.68% |
| 2018 | 134.21% |
| 2017 | -181.87% |
| 2016 | 0.00% |